此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Shoulder Anterior Capsule Block Combined With Supra Scapular Nerve Versus Interscalene Block as Sole Anesthesia in Shoulder Arthroscopy

2026年6月15日 更新者:Zagazig University

Shoulder Anterior Capsule Block Combined With Suprascapular Nerve Block Versus Interscalene Block as a Sole Anesthetic Technique for Shoulder Arthroscopy

Evaluation of shoulder anterior capsule nerve block combined with suprascapular nerve block as an adequate sole anesthetic technique in shoulder arthroscopic surgeries without significant affection of motor power and pulmonary function.

研究概览

详细说明

Ultrasonographic peripheral nerve block has been a popular technique not only for pain management but also for surgical anesthesia especially in patients with comorbidities, avoiding complications associated with general anesthesia (airway-difficulties, hemodynamic instability, etc.) and ensuring excellent pain control, reducing peri-operative consumption of opioids and their side effects, and improving patient satisfaction.

Interscalene block (ISB) is the gold stander anesthetic technique for shoulder surgeries but hemi-diaphragmatic paralysis still problematic. The SHAC is the combination of two different blocks. The first block is the inter fascial space between the deep layer of the deltoid fascia and the superficial layer of the subscapularis fascia, anterior to the subscapularis myotendinous junction. This inter fascial space, we can reach both the axillary nerve and the subscapular nerves, the lateral pectoral nerve, and the musculocutaneous nerve results in achieving adequate anesthesia and analgesia without phrenic nerve affection.

The present study will be conducted to compare of SHAC block combined with suprascapular nerve block and Interscalene block as an anesthetic option in shoulder arthroscopic surgery may allow adequate postoperative analgesia and decrease the overall opioid usage and enhanced patient recovery

研究类型

介入性

注册 (实际的)

50

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Sharqia Province
      • Zagazig、Sharqia Province、埃及
        • Zagazig University Hospitals

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  1. Written informed consent from patients.
  2. BMI less than or equal 30 kgm .
  3. Age 18-75 years old.
  4. ASA class I, II and III.

Exclusion Criteria:

  1. Allergy to local anesthetics.
  2. Infection at site of injection.
  3. Patients with coagulopathy.
  4. Physical and mental disease which could interfere with pain scores evaluation.
  5. pre-existing neuropathy of the operative limb.
  6. Pre-existing sever pulmonary diseases (obstructive or restrictive).
  7. Patients with distorted local anatomy.
  8. Patients with chronic pain syndrom

    -

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:其他
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
有源比较器:Group SHAC block
Group SHAC block: Patients will receive Ultrasound Guided Shoulder Anterior Capsule block and Suprascapular nerve block
Group SHAC block: Patients will receive Ultrasound Guided Shoulder Anterior Capsule block and Suprascapular nerve block
有源比较器:Group IS block
Group IS block: Patients will receive Ultrasound Guided interscalene brachial plexus block.
Group IS block: Patients will receive Ultrasound Guided interscalene brachial plexus block.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Assessment of SHAC block efficacy for postoperative analgesia in shoulder arthroscopic surgeries by using Visual Analogue Scale (VAS)
大体时间:From start of surgery and for the 1st 24 hours postoperatively.
Inter-operative VAS immediately after the block and every 5 minutes for 30 minutes and every 2 hours post-operatively for 24 hours while 0 indicates no pain and 10 the severest pain.
From start of surgery and for the 1st 24 hours postoperatively.
Assessment of SHAC block efficacy for postoperative analgesia in shoulder arthroscopic surgeries by duration of analgesia
大体时间:24 hours postoperatively
Assessment of SHAC block efficacy for postoperative analgesia in shoulder arthroscopic surgeries by duration of analgesia. Duration of postoperative analgesia (from the time of patient recovery till the time of rescue analgesia).
24 hours postoperatively
Assessment of SHAC block efficacy for postoperative analgesia in shoulder arthroscopic surgeries by amount of opioid consumption postoperatively.
大体时间:1st 24 hours postoperatively.
Assessment of SHAC block efficacy for postoperative analgesia in shoulder arthroscopic surgeries by amount of opioid consumption postoperatively. Total dose of morphine per mg used during the 1st 24 hours postoperatively.
1st 24 hours postoperatively.

次要结果测量

结果测量
措施说明
大体时间
Safety of SHAC block by monitoring of complications eg. local anesthetic toxicity , hemodynamics instability, phrenic nerve affection, pneumothorax.
大体时间:From start of surgery and for the 1st 24 hours.
Monitoring of complications like local anesthetic toxicity ( restlessness, irritability, confusion, convulsions and arrhythmias) hemodynamics instability, phrenic nerve affection ( diaphragmatic paralysis) , pneumothorax ( decrease in oxygen saturation monitoring, tachypnea, diminished air entry on affected side by auscultation).
From start of surgery and for the 1st 24 hours.
Patient satisfaction with the anesthesia and analgesia during and after surgery
大体时间:From start of surgery and for the 1st 24 hours postoperatively.
Patient satisfaction was evaluated by using satisfaction score and patients were graded on a 5-point scale: 1 = very dissatisfied, 2 = dissatisfied, 3 = neutral, 4 = satisfied, 5 = very satisfied, and assessed at 24 h post-operation
From start of surgery and for the 1st 24 hours postoperatively.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2024年7月1日

初级完成 (实际的)

2025年6月1日

研究完成 (实际的)

2026年2月1日

研究注册日期

首次提交

2026年5月11日

首先提交符合 QC 标准的

2026年6月15日

首次发布 (实际的)

2026年6月16日

研究记录更新

最后更新发布 (实际的)

2026年6月16日

上次提交的符合 QC 标准的更新

2026年6月15日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

其他研究编号

  • 387/10 - june-2024

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅